Biodexa Pharmaceuticals (BDRX) Interest Income - Net (2015 - 2020)
Biodexa Pharmaceuticals (BDRX) reported Interest Income - Net of -$101674.7 for Q4 2020, down 182.37% on a YoY basis from $123429.6 in Q1 2020, and up 84.77% sequentially from -$667418.6 in Q3 2020.
Biodexa Pharmaceuticals (BDRX) Interest Income - Net (2015 - 2020) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 4 years of Interest Income - Net data on file, last reported at -$101674.7 in Q4 2020.
- For the quarter ending Q4 2020, Interest Income - Net fell 182.37% year-over-year to -$101674.7; the trailing twelve-month figure through Dec 2020 stood at -$2.2 million (changed N/A YoY), and the FY2025 full-year result was -$3.4 million, up 24.36% from the prior year.
- Interest Income - Net grew to -$101674.7 in Q4 2020, from -$667418.6 in the prior quarter.
- In the past five years, Interest Income - Net ranged from a high of $123429.6 in Q4 2019 to a low of -$1.6 million in Q4 2016.
- A 3-year average of -$554274.2 and a median of -$384546.7 in 2020 frame the typical range for Interest Income - Net.
- Across the five-year window, Interest Income - Net surged 38.58% in 2016 and tumbled 182.37% in 2020, its largest moves.
- Tracing BDRX's Interest Income - Net over 3 years: stood at -$1.6 million in 2016, then surged by 107.85% to $123429.6 in 2019, then plunged by 182.37% to -$101674.7 in 2020.
- Business Quant data shows BDRX's Interest Income - Net at -$101674.7 in Q4 2020, -$667418.6 in Q3 2020, and $123429.6 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -17.04 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -101,674.73 |
| Sep 10, 2020 | -667,418.59 |
| Dec 31, 2019 | 123,429.59 |
| Dec 31, 2016 | -1.57 Mn |
| Dec 31, 2015 | -2.56 Mn |